Cash & equivalents increased 26.7%
Cash & equivalents changed +26.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +26.7% from the comparable as-filed period.
Debt changed +52.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +648 basis points from the comparable as-filed period.
Inventory changed -30.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +124.1% from the comparable as-filed period.
Research & development changed -21.8% from the comparable as-filed period.
Revenue changed -14.0% from the comparable as-filed period.
Selling, general & administrative changed -11.8% from the comparable as-filed period.
Gross profit changed +0.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.